NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of raw human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.
Palo Alto, US
8 (est)-20%

Key People at NuMedii

Craig Webb

Craig Webb

Chief Scientific Officer
Scott Saywell

Scott Saywell

Corporate Development
Gini Deshpande

Gini Deshpande

Founder and Chief Executive Officer

NuMedii Locations

Palo Alto, US

NuMedii Metrics

NuMedii Summary

Founding Date


Total Funding

$5.5 M

Latest funding size

$2 M

Time since last funding

about 1 year


NuMedii Online Presence

NuMedii Company Life